Wyeth is now a wholly owned subsidiary of Pfizer

31 marketed · 17 in Phase 3

Quick facts

Marketed products

Phase 3 pipeline

Phase 2 pipeline

Phase 1 pipeline

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Frequently asked questions about Wyeth is now a wholly owned subsidiary of Pfizer

What are Wyeth is now a wholly owned subsidiary of Pfizer's marketed drugs?

Top marketed products include 7-valent pneumococcal conjugate vaccine, Advante, ceftriaxone plus metronidazole, ceftriaxone sodium + metronidazole, Effexor, Effexor® (Venlafaxine).

What is Wyeth is now a wholly owned subsidiary of Pfizer's pipeline?

Wyeth is now a wholly owned subsidiary of Pfizer has 17 drugs in Phase 3, 13 in Phase 2, 16 in Phase 1. Late-stage candidates include 23vPS, 7vPnC, ATRA plus 6-MP and MTX, Bazedoxifene Acetate (TSE-424).

Related